Values First Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$206K Buy
3,280
+70
+2% +$5.6K 0.11% 159
2025
Q4
$306K Buy
3,210
+275
+9% +$27K 0.16% 137
2025
Q3
$287K Sell
2,935
-155
-5% -$16.1K 0.15% 137
2025
Q2
$332K Sell
3,090
-18
-0.6% -$1.82K 0.18% 141
2025
Q1
$313K Sell
3,108
-2
-0.1% -$201 0.18% 138
2024
Q4
$278K Buy
3,110
+2,771
+817% +$244K 0.15% 147
2024
Q3
$28.4K Buy
+339
New +$26.7K 0.02% 258

Other funds holding BSX

Values First Advisors's BSX Position: Q1 2026 in Review

Values First Advisors increased its Boston Scientific (BSX) stake by 2.2% in Q1 2026, buying an estimated $5.6K and bringing the position to 3,280 shares worth $206K. The position accounts for 0.11% of the portfolio, ranked #159.

Values First Advisors first reported a position in BSX in Q3 2024 and has held it in 7 quarters since. The position peaked at $332K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Values First Advisors held 3,280 shares of Boston Scientific worth $206K as of Q1 2026.
  • Values First Advisors bought 70 Boston Scientific shares in Q1 2026, an estimated $5.6K.
  • Boston Scientific made up 0.11% of Values First Advisors's portfolio in Q1 2026, its #159 holding.
  • Values First Advisors first reported a position in Boston Scientific in Q3 2024 and has held it in 7 quarters since.
  • Values First Advisors's Boston Scientific position peaked at $332K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Values First Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.